Licensing deal to boost HIV drug access
by on Jul.12, 2011, under Health and Fitness
US pharmaceutical giant Gilead Sciences and an NGO called the Medicines Patent Pool announced a deal on Tuesday aimed at boosting access to HIV drugs in poorer countries through generic manufacturing.
View full post on Yahoo! Health News
